Free Trial
NASDAQ:EVGN

Evogene (EVGN) Stock Price, News & Analysis

Evogene logo
$1.36 0.00 (0.00%)
Closing price 07/3/2025 03:50 PM Eastern
Extended Trading
$1.36 -0.01 (-0.37%)
As of 07/3/2025 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Evogene Stock (NASDAQ:EVGN)

Key Stats

Today's Range
$1.34
$1.38
50-Day Range
$1.10
$2.26
52-Week Range
$0.95
$6.80
Volume
44,787 shs
Average Volume
625,226 shs
Market Capitalization
$7.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Buy

Company Overview

Evogene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

EVGN MarketRank™: 

Evogene scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Evogene has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Evogene has only been the subject of 1 research reports in the past 90 days.

  • Read more about Evogene's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Evogene is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Evogene is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Evogene has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Evogene's valuation and earnings.
  • Percentage of Shares Shorted

    7.54% of the float of Evogene has been sold short.
  • Short Interest Ratio / Days to Cover

    Evogene has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Evogene has recently increased by 320.44%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Evogene does not currently pay a dividend.

  • Dividend Growth

    Evogene does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.54% of the float of Evogene has been sold short.
  • Short Interest Ratio / Days to Cover

    Evogene has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Evogene has recently increased by 320.44%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    8 people have searched for EVGN on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Evogene insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.40% of the stock of Evogene is held by insiders.

  • Percentage Held by Institutions

    Only 10.40% of the stock of Evogene is held by institutions.

  • Read more about Evogene's insider trading history.
Receive EVGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter.

EVGN Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Evogene Ltd. Reports Q1 2025 Financial Results
Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript
See More Headlines

EVGN Stock Analysis - Frequently Asked Questions

Evogene's stock was trading at $1.87 at the start of the year. Since then, EVGN shares have decreased by 27.3% and is now trading at $1.36.

Evogene Ltd. (NASDAQ:EVGN) released its earnings results on Wednesday, May, 21st. The biotechnology company reported ($0.38) earnings per share for the quarter, beating analysts' consensus estimates of ($0.50) by $0.12. The biotechnology company had revenue of $2.44 million for the quarter, compared to analysts' expectations of $4.42 million. Evogene had a negative net margin of 224.82% and a negative trailing twelve-month return on equity of 102.40%.
Read the conference call transcript
.

Evogene's stock reverse split before market open on Thursday, July 25th 2024.The 1-10 reverse split was announced on Tuesday, July 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of EVGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evogene investors own include Tesla (TSLA), NIO (NIO), NVIDIA (NVDA), Plug Power (PLUG), Riot Platforms (RIOT) and AquaBounty Technologies (AQB).

Company Calendar

Last Earnings
5/21/2025
Today
7/03/2025
Next Earnings (Estimated)
8/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Chemicals
Current Symbol
NASDAQ:EVGN
Employees
140
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.50
High Stock Price Target
$3.50
Low Stock Price Target
$3.50
Potential Upside/Downside
+157.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.49 million
Net Margins
-224.82%
Pretax Margin
-254.09%

Debt

Sales & Book Value

Annual Sales
$8.51 million
Price / Cash Flow
N/A
Book Value
$2.77 per share
Price / Book
0.49

Miscellaneous

Free Float
4,968,000
Market Cap
$7.30 million
Optionable
Optionable
Beta
1.58

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:EVGN) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners